BetaShares Global Healthcare ETF - Currency Hedged
The BetaShares Global Healthcare ETF - Currency Hedged (AU:DRUG) is a meticulously crafted investment vehicle designed to give investors seamless access to the dynamic global healthcare sector. This ETF is uniquely positioned within the sector-focused category, offering a targeted yet broad-based approach to capitalizing on healthcare innovations and advancements worldwide. As healthcare continues to evolve as a critical driver of global economic growth and societal well-being, this ETF provides exposure to a diversified portfolio of leading healthcare companies, including pharmaceuticals, biotechnology, and medical devices. The currency-hedged feature ensures that investors are shielded from adverse currency movements, preserving the value of their international investments. With AU:DRUG, investors can tap into the healthcare industry's robust potential, benefiting from the sector's resilience and growth prospects while maintaining a strategic edge in their portfolios.
Asset Class
Equity
Region
Global
Issuer
BetaShares
Index Tracked
Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD
Ticker Symbol
AU:DRUG
BetaShares Global Healthcare ETF - Currency Hedged (DRUG) Fund Flow Chart
BetaShares Global Healthcare ETF - Currency Hedged (DRUG) 1 year Net Flows: 27M
DRUG ETF FAQ
What was AU:DRUG’s price range in the past 12 months?
AU:DRUG lowest ETF price was 7.82 and its highest was 9.17 in the past 12 months.
What is the AUM of AU:DRUG?
As of Jan 29, 2025 The AUM of AU:DRUG is 191.20M.
Is AU:DRUG overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does AU:DRUG pay dividends?
AU:DRUG does not currently pay dividends.
How many shares outstanding does AU:DRUG have?
Currently, no data Available
Which hedge fund is a major shareholder of AU:DRUG?
Currently, no hedge funds are holding shares in AU:DRUG